INB03 for the Treatment of Pulmonary Complications From COVID-19
Public ClinicalTrials.gov record NCT04370236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of INB03 in the Treatment of Participants With Pulmonary Complications From Coronavirus Disease (COVID-19)
Study identification
- NCT ID
- NCT04370236
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Inmune Bio, Inc.
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- INB03 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2020
- Primary completion
- Oct 12, 2021
- Completion
- Nov 17, 2021
- Last update posted
- May 18, 2026
2020 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NEA Baptist | Jonesboro | Arkansas | 72401 | — |
| St. Bernard's | Jonesboro | Arkansas | 72401 | — |
| Jewish Hospital | Louisville | Kentucky | 40202 | — |
| Mississippi Baptist | Kosciusko | Mississippi | 39090 | — |
| Baptist Memorial Hospital-DeSoto | Southard | Missouri | 38671 | — |
| Richmond University Medical Center | Staten Island | New York | 10312 | — |
| Baptist Clinical Research Institute | Memphis | Tennessee | 38120 | — |
| Memorial Hermann | Houston | Texas | 77030 | — |
| Memorial Hermann Southeast | Houston | Texas | 77089 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04370236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04370236 live on ClinicalTrials.gov.